THY1 and cancer: However, the specific molecular mechanisms have not been fully described; therefore, future research should focus on the specific molecular mechanisms of CD90+ fibroblasts in different tissues, organs, and cancer cells to provide a theoretical basis for the development of precise therapeutic protocols and targeted therapies in the clinical setting.